* Si quieres que hagamos difusión de tus artículos escríbenos a documentacion.iacs@aragon.es
Variability of the Prevalence of Depression in Function of Sociodemographic and Environmental Factors: Ecological Model.
Llorente JM, Oliván-Blázquez B, Zuñiga-Antón M, Masluk B, Andrés E, García-Campayo J, Magallón-Botaya R.
Front Psychol. 2018
Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
Guedeney P, Tchétché D, Petronio AS, Mehilli J, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Iadanza A, Sardella G, Van Mieghem NM, Sorrentino S, Claessen BEPM, Chandrasekhar J, Vogel B, Kalkman DN, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer-Grazia MC, Naber C, Kievit P, Baber U, Sharma S, Morice MC, Chieffo A, Mehran R; WIN TAVI Investigators.
Catheter Cardiovasc Interv. 2018
Aortic curvature remodeling after thoracic endovascular aortic repair: assessing device conformability, employing image vector analysis.
Mestres G, Blanco C, Martinez I, Noya JF, Inaraja GC, Antonio Del Castro J, Salmeron LM, Malo N, Riambau V.
Ann Vasc Surg. 2018
Kidney transplant from controlled donors following circulatory death: Results from the GEODAS-3 multicentre study.
Portolés JM, Pérez-Sáez MJ, López-Sánchez P, Lafuente-Covarrubias O, Juega J, Hernández D, Espí J, Navarro MD, Mazuecos MA, Rodríguez-Ferrero ML, Maruri-Kareaga N, Moreso F, Melilli E, de Souza E, Ruiz JC, Llamas F, Gutiérrez-Dalmau A, Guirado L, Martín-Moreno P, Pérez Flores I, Fernández-García A, Jiménez C, Gavela E, Ramos A, Pascual J; en representación del grupo GEODAS.
Nefrologia. 2018
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.
Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A.
BMC Cancer. 2018
BRIVA-LIFE – a multicentre retrospective study of the long-term use of brivaracetam in clinical practice.
Villanueva V, López-González FJ, Mauri JA, Rodriguez-Uranga J, Olivé-Gadea M, Montoya J, Ruiz-Giménez J, Zurita J; BRIVA-LIFE study group.
Acta Neurol Scand. 2018
Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients.
Hernández-Boluda JC, Pereira A, Pastor-Galán I, Alvarez-Larrán A, Savchuk A, Puerta JM, Sánchez-Pina JM, Collado R, Díaz-González A, Angona A, Sagüés M, García-Gutiérrez V, Boqué C, Osorio S, Vallansot R, Palomera L, Mendizábal A, Casado LF, Pérez-Encinas M, Pérez-López R, Ferrer-Marín F, Sánchez-Guijo F, García C, Heras NL, López-Lorenzo JL, Cervantes F, Steegmann JL; Grupo Español de Leucemia Mieloide Crónica (GELMC).
Blood Cancer J. 2018
Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma.
Méndez-Vidal MJ, Molina Á, Anido U, Chirivella I, Etxaniz O, Fernández-Parra E, Guix M, Hernández C, Lambea J, Montesa Á, Pinto Á, Ros S, Gallardo E.
BMC Pharmacol Toxicol. 2018
Heart Failure Care Dyadic Typology: Initial Conceptualization, Advances in Thinking, and Future Directions of a Clinically Relevant Classification System.
Buck HG, Hupcey J, Juárez-Vela R, Vellone E, Riegel B.
J Cardiovasc Nurs. 2018